Financials data is unavailable for this security.
View more
Year on year Bioxyne Ltd had net income fall 586.87% from a loss of 1.94m to a larger loss of 13.33m despite a 80.91% increase in revenues from 5.15m to 9.33m.
Gross margin | 36.44% |
---|---|
Net profit margin | -139.14% |
Operating margin | -142.72% |
Return on assets | -106.39% |
---|---|
Return on equity | -136.57% |
Return on investment | -134.91% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Bioxyne Ltd fell by 2.82m. Cash Flow from Financing totalled 1.21m or 12.98% of revenues. In addition the company used 3.56m for operations while cash used for investing totalled 492.66k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0018 |
---|---|
Tangible book value per share | 0.0016 |
More ▼
Balance sheet in AUDView more
Current ratio | 1.92 |
---|---|
Quick ratio | 1.18 |
Total debt/total equity | 0.0508 |
---|---|
Total debt/total capital | 0.0526 |
More ▼